- AU$19.00m
- AU$9.94m
- AU$0.43m
Brief: INOVIQ Ltd Expands Exosome Leadership With New Patent Application
Brief: Inoviq Seeks Trading Halt
Brief: INOVIQ Says Appointment Of David Williams As Chairman Elect
Brief: Inoviq And Researchdx Sign Exo-Net Services Agreement For USA
Brief: Inoviq And Promega Announce Global Joint Marketing Agreement
Australia's INOVIQ eyes best day in over 2 yrs on upbeat cancer test results
Brief: Inoviq Says HY Total Comprehensive Loss Attributable A$5.8 Mln Versus Loss A$2.6 Mln
Brief: Inoviq Says Settled Legal Proceeding Related To Bard1 Performance Shares
Australian medical diagnostics firm INOVIQ rises on streamlining ops
Australia's Inoviq surges on agreement with Canadian biotech firm
Brief: Inoviq Says Signed A Contract Research Agreement With Nicoya Lifesciences
Brief: Inoviq Says Mark Edwards Appointed CFO
Brief: Inoviq Ltd Posts FY Total Comprehensive Loss A$6.3 Million
Australia's Inoviq rises on grant of U.S. patent for cancer study
Brief: Inoviq Engages Us-Based Percorso Life Sciences Under Services Agreement
Australia's Inoviq eyes best day in nearly 3 weeks on patent grant
Australia's Inoviq eyes best day in 7 weeks on manufacturing deal
Brief: Inoviq Says Co Has Executed A Master Manufacturing Agreement With Mp Biomedicals
Brief: Inoviq Ltd Engages Researchdx To Develop And Validate Subb2m-Based Tests